FDA permits marketing of first U.S. test labeled for simultaneous detection of tuberculosis bacteria and resistance to the antibiotic rifampin.

NIH-funded study suggests test may increase treatment in primary care settings.

Re: Further research into sutezolid urgently needed for tuberculosis

There is increasing evidence from several large-scale MDR-tuberculosis programmes of improved access to care and management through decentralisation, without compromising treatment outcomes.

TAG and TB CAB sent letters to manufacturers of Quantiferon TB Gold and Immucheck TB Platinum expressing concerns that their tests, blood-based interferon gamma release assays indicated only for latent TB infection detection, are misleadingly marketed in India as tests for active TB.

Tuberculosis accounts for the second most important infectious disease burden in Europe.

The report reviews the landscape of TB diagnostics - considering current and expected future technologies, as well as critical market issues, highlighting potential market-based approaches to address shortcomings and improve market function.

The cuts come at a time when many in the tuberculosis community feel that new treatments are within reach.

The use of rapid molecular assays has diagnostic value in tuberculosis identification and detection of drug resistance, although there is not enough evidence to recommend these tools in all populations and situations and they should not replace standard diagnostic methods.

A new combination treatment has been tested in Southern Africa, but it is not available locally.